← Leaderboards
Claudia Michelle Campbell
Johns Hopkins University
$14,946,130
Attributed
$30,422,245
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.5M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,422,245 · 11
By mechanism
UH3$13,841,221 · 1
R01$12,500,335 · 5
U24$1,893,837 · 1
UG3$887,373 · 1
K23$880,470 · 1
K24$323,998 · 1
Top collaborators
- Steven P Cohen9 shared
- Renan C Castillo8 shared
- Kelly E Dunn8 shared
- Jennifer A Haythornthwaite4 shared
- Kalpna Gupta2 shared
- Wally R Smith2 shared
- Robert Willson Hurley1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Eric C Strain$21,082,541
- Kelly E Dunn$16,976,262
- Ryan G Vandrey$11,502,880
- Renan C Castillo$6,430,047
- Steven P Cohen$4,899,825
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainAffectChronic PainOpioidDisabilityResponseReportingLaboratoriesKnee OsteoarthritisPain ManagementPersistent PainChronicSleepEffectivenessDegenerative PolyarthritisBehavioralPharmaceutical PreparationsExhibitsOpioid UseClinical PainEconomic BurdenFunctional DisabilityOperative Surgical ProceduresAnalgesics
Grant awards (41)
Sickle Cell Disease Pain Analgesia And Integrative Network$929,890
U24 · FY2025 · AT
Sickle Cell Disease Pain Analgesia And Integrative Network$963,947
U24 · FY2024 · AT
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis$383,980
R01 · FY2024 · AR · contact PI
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain$1,164,062
UH3 · FY2023 · AR · contact PI
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis$410,292
R01 · FY2023 · AR · contact PI
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain$155,564
UH3 · FY2023 · AR · contact PI
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain$2,951,097
UH3 · FY2022 · AR · contact PI
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis$403,080
R01 · FY2022 · AR · contact PI
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain$155,564
UH3 · FY2022 · AR · contact PI
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain$5,382,096
UH3 · FY2021 · AR · contact PI
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans$657,143
R01 · FY2021 · DA
Increasing Participant Diversity in a 'Sequenced-Strategy to Improve Outcomes in people with Knee Osteoarthritis Pain (SKOAP)$523,792
UH3 · FY2021 · AR
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis$408,407
R01 · FY2021 · AR · contact PI
Mentorship of Junior Investigators on HEAL-SKOAP$323,998
K24 · FY2021 · AR · contact PI
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain$155,564
UH3 · FY2021 · AR
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain$3,353,482
UH3 · FY2020 · AR
Opioid and cannabinoid combinations in laboratory and clinical pain$747,430
R01 · FY2020 · DA · contact PI
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain$887,373
UG3 · FY2019 · AR
Sleep and Pain in Sickle Cell Disease$763,817
R01 · FY2019 · HL · contact PI
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans$689,500
R01 · FY2019 · DA
Sleep and Pain in Sickle Cell Disease$784,457
R01 · FY2018 · HL · contact PI
Opioid and cannabinoid combinations in laboratory and clinical pain$752,257
R01 · FY2018 · DA · contact PI
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans$694,031
R01 · FY2018 · DA
Ethnic differences in endogenous pain regulation: PET imaging of opioid receptors$405,000
R01 · FY2018 · MD · contact PI
Ethnic differences in endogenous pain regulation: PET imaging of opioid receptors$100,000
R01 · FY2018 · MD · contact PI
Sleep and Pain in Sickle Cell Disease$792,691
R01 · FY2017 · HL
Opioid and cannabinoid combinations in laboratory and clinical pain$749,483
R01 · FY2017 · DA · contact PI
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans$681,242
R01 · FY2017 · DA
Ethnic differences in endogenous pain regulation: PET imaging of opioid receptors$405,000
R01 · FY2017 · MD · contact PI
Sleep and Pain in Sickle Cell Disease$775,356
R01 · FY2016 · HL
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans$682,169
R01 · FY2016 · DA
Ethnic differences in endogenous pain regulation: PET imaging of opioid receptors$405,000
R01 · FY2016 · MD · contact PI
Ethnic differences in endogenous pain regulation: PET imaging of opioid receptors$405,000
R01 · FY2015 · MD · contact PI
Ethnic differences in endogenous pain regulation: PET imaging of opioid receptors$405,000
R01 · FY2014 · MD · contact PI
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids$176,094
K23 · FY2014 · NS · contact PI
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids$176,094
K23 · FY2013 · NS · contact PI
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids$176,094
K23 · FY2012 · NS · contact PI
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids$176,094
K23 · FY2011 · NS · contact PI
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids$176,094
K23 · FY2010 · NS · contact PI
Ethnic differences in effects of opioid blockade and behavioral analgesia on pain$48,185
F32 · FY2009 · NS · contact PI
Ethnic differences in effects of opioid blockade and behavioral analgesia on pain$46,826
F32 · FY2008 · NS · contact PI